CHARLESTON Fingers were pointed and blame was thrown all around a federal courtroom as a retired Drug Enforcement Administration official and attorneys for three drug distributors butted heads for a second full day of testimony.
Joe Rannazzisi, the former director of the DEA’s Office of Diversion Control, was under cross-examination for the entirety of June 9’s testimony by attorneys for AmerisourceBergen, Cardinal Health and McKesson.
Huntington and Cabell County sued the nation s three largest pharmaceutical distribution companies in 2017 seeking to hold the companies accountable for their alleged part in the opioid epidemic by sending more than 540,000 opioids each month to independent and chain pharmacies – excluding hospitals and/or hospital pharmacies – located in Cabell County.
CHARLESTON, W.Va. (AP) Opioid distribution companies and federal regulators pointed the finger at each other as a contributing factor in the nation’s opioid epidemic during a landmark civil trial in West Virginia. A former Drug Enforcement Administration official and the distributors each argued Wednesday that the other side disregarded requests to comply with regulations […]
CHARLESTON Fingers were pointed and blame was thrown all around a federal courtroom as a retired Drug Enforcement Administration official and attorneys for three drug distributors butted heads for a second full day of testimony.
CHARLESTON – A key former Drug Enforcement Administration official spent the day on the witness stand giving testimony between objections, legal limitations and frustrations.
CHARLESTON, W.Va.
A retired high-ranking official with the Drug Enforcement Administration has testified that three large opioid distributors had a “systematic failure” in monitoring suspicious pill orders.
Joe Rannazzisi, former head of the Office of Diversion Control for the DEA from 2006 to 2015, testified Tuesday in Charleston in a landmark civil case brought by Cabell County and the city of Huntington that accuses AmerisourceBergen, Cardinal Health Inc. and McKesson Corp. of fueling the U.S. opioid epidemic.
The companies say poor communication and pill quotas set by federal agents are to blame, along with a rise in prescriptions written by doctors.